News from EVANIUM

Launches, awards, partnerships and updates on OPTISOLV® Technology, straight from our team in Regensburg.

EVANIUM researcher working in the laboratory

EVANIUM secures successful seed funding – Report in the Mittelbayerische Zeitung

November 30, 2023

The Mittelbayerische Zeitung reported on EVANIUM’s successful seed funding round in 2023, a crucial milestone for the growth of our team in Regensburg.

GründerLIFT #052 – Is the alignment correct?

November 23, 2023

In episode #052 of the GründerLIFT podcast, co-founder and CEO Felix Rolka takes listeners behind the scenes of EVANIUM’s journey since the Startupfactory 2017.

Blue armchair and floor lamp in a bright, minimal room

Interview with EVANIUM Co-Founder David Ofner

May 23, 2023

David Ofner, co-founder of EVANIUM, oversees research on improving the water solubility and bioavailability of plant-based substances. Here he shares what drives him and his vision for the company.

Laboratory glassware with blue liquid held by a scientist in gloves

FAH member EVANIUM Healthcare GmbH introduces itself

December 14, 2022

EVANIUM develops IP-protected plant-based health ingredients. With OPTISOLV® Technology, we make bioactive flavonoids highly soluble, stable and bioavailable.

In the media

EVANIUM in the press

Coverage from NutraIngredients, Vitafoods Insights, EU-Startups and others, plus our press releases, boilerplate and press contact.

Questions about OPTISOLV®?

Talk to our team about ingredients, samples or a joint project.